ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FOQUEST Receives Approval for Expanded Indication for Children and Adolescents with ADHD
March 13, 2019Today's news is an exciting development for young Canadians and their families who now have a new option to help manage their ADHD," said Purdue Pharma (Canada) President and CEO David Pidduck. -
FDA Approves Expanded Indication for Truvada (emtricitabine and tenofovir disoproxil fumarate) for Reducing the Risk of Acquiring HIV-1 in Adolescents
May 17, 2018Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Truvada (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
Pharma Sources Insight January 2025
